Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001061507 | SCV001226252 | pathogenic | Bardet-Biedl syndrome | 2023-08-08 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs767005321, gnomAD 0.004%). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 856112). This premature translational stop signal has been observed in individual(s) with Bardet-Biedl syndrome (PMID: 20177705). This sequence change creates a premature translational stop signal (p.Arg278*) in the BBS9 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BBS9 are known to be pathogenic (PMID: 16380913, 20177705). |
Blueprint Genetics | RCV001073836 | SCV001239400 | pathogenic | Retinal dystrophy | 2018-06-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001702081 | SCV003194836 | likely pathogenic | not provided | 2023-01-17 | criteria provided, single submitter | clinical testing | Observed in multiple affected patients in one family with Bardet-Biedl syndrome in the literature (Muller et al., 2010); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 20177705) |
Baylor Genetics | RCV003462590 | SCV004214187 | pathogenic | Bardet-Biedl syndrome 9 | 2024-03-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV003462590 | SCV005666957 | pathogenic | Bardet-Biedl syndrome 9 | 2024-03-25 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001702081 | SCV001927813 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001702081 | SCV001955838 | pathogenic | not provided | no assertion criteria provided | clinical testing |